A new tactic in the battle against heart problems employing nanoengineered molecules called "Nanolipoblockers" As frontline infantry against harmful cholesterol is showing promise in early laboratory studies at Rutgers University. Researchers propose a way to combat clogged arteries by attacking how bad cholesterol triggers inflammation and causes plaque buildup at specific blood vessel sites. The approach creates clusters of nanoengineered substances that target specific receptor compounds on cell membranes and block oxidized LDLs from attaching.A new tactic in the battle against heart problems employing nanoengineered molecules called "Nanolipoblockers" As frontline infantry against harmful cholesterol is showing promise }